4.5 Review Book Chapter

Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis

Journal

ANNUAL REVIEW OF NUTRITION, VOL 38
Volume 38, Issue -, Pages 173-196

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-nutr-071816-064800

Keywords

FGF21; macronutrient; beta-klotho; adipose; thermogenesis; alcohol

Funding

  1. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106104] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER
  3. NIDDK NIH HHS [R01 DK106104] Funding Source: Medline
  4. NIGMS NIH HHS [T32 GM067795] Funding Source: Medline

Ask authors/readers for more resources

Fibroblast growth factor 21 (FGF21) is an endocrine hormone derived from the liver that exerts pleiotropic effects on the body to maintain overall metabolic homeostasis. During the past decade, there has been an enormous effort made to understand the physiological roles of FGF21 in regulating metabolism and to identify the mechanism for its potent pharmacological effects to reverse diabetes and obesity. Through both human and rodent studies, it is now evident that FGF21 levels are dynamically regulated by nutrient sensing, and consequently FGF21 functions as a critical regulator of nutrient homeostasis. In addition, recent studies using new genetic and molecular tools have provided critical insight into the actions of this endocrine factor. This review examines the numerous functions of FGF21 and highlights the therapeutic potential of FGF21-targeted pathways for treating metabolic disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available